Literature DB >> 17879111

Combined Scimitar syndrome and interruption of the inferior vena cava causing mega-azygous and hemiazygous veins.

S Bruce Greenberg1.   

Abstract

Computed tomography angiography detected scimitar syndrome with venous drainage to the inferior vena cava caudal to an interruption of the inferior vena cava in a 48-year-old woman. The hepatic veins drained to the supra-hepatic portion of the inferior vena cava cephalic to the interruption, which was a short area of atresia. Azygous and hemiazygous veins were massively enlarged since they drained the right lung, abdomen viscera exclusive of the liver and lower extremities. Inferior vena cava interruption by a short, focal atresia has not previously been described. The inferior vena cava immediately caudal to the interruption is presumed to remain patent because of the scimitar vein flow.

Entities:  

Mesh:

Year:  2007        PMID: 17879111     DOI: 10.1007/s00246-007-9100-4

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  4 in total

1.  The value of ultrasonography in interrupted inferior vena cava with azygos continuation.

Authors:  I Mihmanli; N Bulakbasi; F Kantarci; I Adaletli; Y Pabuscu
Journal:  Eur J Ultrasound       Date:  2001-12

Review 2.  Obstruction of the inferior vena cava: a multiple-modality demonstration of causes, manifestations, and collateral pathways.

Authors:  A H Sonin; M J Mazer; T A Powers
Journal:  Radiographics       Date:  1992-03       Impact factor: 5.333

3.  The syndrome of left isomerism: sonographic findings and outcome in prenatally diagnosed cases.

Authors:  Christoph Berg; Annegret Geipel; Daniel Kamil; Mareike Knüppel; Johannes Breuer; Martin Krapp; Ahmet Baschat; Ute Germer; Manfred Hansmann; Ulrich Gembruch
Journal:  J Ultrasound Med       Date:  2005-07       Impact factor: 2.153

4.  Magnetic resonance imaging of developmental venous anomalies.

Authors:  M R Fisher; H Hricak; C B Higgins
Journal:  AJR Am J Roentgenol       Date:  1985-10       Impact factor: 3.959

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.